The 120 kD product of the c-cbl oncogene is rapidly tyrosine phosphorylated and recruited to the EGF receptor following ligand binding. Cbl's oncogenic potential is activated by a large carboxy-terminal truncation that generated v-cbl and removes the Ring ®nger and proline-rich SH3-binding domains. Here we show that this truncation reveals a novel and highly conserved domain that can interact directly with the EGF receptor in a phosphorylation dependent manner. Furthermore we demonstrate that the v-cbl domain is not utilized by c-cbl for recruitment to the receptor since this binding property is not evident in c-cbl constructs with proline domain deletions, and it is only revealed following deletion of the Ring ®nger. We also analyse a loss-of-function mutation from the C. elegans homologue, sli-1, and show that the corresponding mutation in v-cbl ablates transformation and EGF receptor association. Thus our ®ndings provide further evidence that v-cbl possesses a novel and evolutionarily conserved phosphotyrosine binding domain and that the dual capability of EGF receptor binding by cbl involves two distinct mechanisms. In addition these ®ndings raise the possibility that v-cbl may transform by competing with c-cbl for phosphorylated binding sites on activated receptor complexes.Keywords: growth factor; oncogene; receptor; signal transduction; tyrosine kinase Introduction v-cbl is the transforming gene of the Cas NS-1 retrovirus which arose by recombination between the murine Cas-Br-M virus and c-cbl sequences . Cas NS-1 induces pre-B cell lymphomas and myelogenous leukemias in mice and acute transformation of immortalized rodent ®broblasts. The 40 kD protein encoded by v-cbl is markedly truncated compared with the cellular homologue, comprising the amino-terminal 38% of the c-cbl encoded protein (Blake et al., 1991). The protein product of c-cbl is a 120 kD cytoplasmic protein and unlike v-cbl its overexpression is not associated with tumorigenesis (Blake et al., 1993).Gene bank searches have not revealed any known genes with signi®cant similarities to c-cbl, and as such the sequence has not provided de®nitive clues for a possible function. However analysis of the sequence reveals an abundance of positively charged residues in the amino-terminal v-cbl region, a Ring ®nger motif and a proline-rich domain of 200 amino acids which contains many Src homology (SH) 3 binding domains (Blake et al., 1991). The recent ®nding that a 17 amino acid deletion at the amino-terminal end of the Ring ®nger will also activate cbl's oncogenic potential has provided important clues in studying cbl's role in tumorigenesis (Andoniou et al., 1994). We found that this form of cbl, which was generated from a splice acceptor site mutation in the 70Z/3 pre-B cell lymphoma, has an enhanced susceptibility to be tyrosine phosphorylated compared to wild type p120 cbl (Andoniou et al., 1994;Bowtell and Langdon, 1995;Andoniou et al., 1996). Thus deregulation of cbl tyrosine phosphorylation is associated with tumorigenesis.Numerous studies have ...